Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
US FDA extends review of Bayer's menopause relief drug
01:00pm, Friday, 25'th Jul 2025
The U.S. Food and Drug Administration has extended its review of Bayer's experimental menopause relief drug, the German drugmaker said on Friday.
Bayer Provides Regulatory Update on Elinzanetant for the Treatment of Moderate to Severe Hot Flashes Due to Menopause
12:30pm, Friday, 25'th Jul 2025
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Provides Regulatory Update on Elinzanetant for the Treatment of Moderate to Severe Hot Flashes Due to Menopause.
Best Value Stocks to Buy for July 22nd
10:01am, Tuesday, 22'nd Jul 2025
OPRT, BAYRY and SHG made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 22, 2025.
New Strong Buy Stocks for July 22nd
07:10am, Tuesday, 22'nd Jul 2025
BTG, PGR, BAYRY, BCH and LNW have been added to the Zacks Rank #1 (Strong Buy) List on July 22, 2025.
Bayer extends contract of CEO until March 2029
10:39am, Wednesday, 16'th Jul 2025
Germany's Bayer said on Wednesday that its supervisory board had extended the contract of CEO Bill Anderson until March 31, 2029.
BAYRY Skyrockets 62.9% YTD: Should You Buy or Sell the Stock?
09:26am, Wednesday, 16'th Jul 2025
Bayer's shares are up 62.9% YTD as new drug approvals and a streamlined model fuel a sharp pharma turnaround.
Bayer: Upside Compelling - Buy
07:46am, Wednesday, 16'th Jul 2025
Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside. The main risks are ongoing glyphosate litigation and pharma pricing pressures
Bayer Gets FDA Nod for Label Expansion of Kerendia in Heart Failure
10:36am, Monday, 14'th Jul 2025
BAYRY wins FDA nod to expand Kerendia's label, making it the only approved non-steroidal MR antagonist for two major conditions.
Bayer Wins Hormone-Free Treatment Approval for Women in the UK
11:11am, Friday, 11'th Jul 2025
BAYRY secures first global approval for Lynkuet in the UK, a hormone-free treatment for menopause-related hot flashes.
Best Value Stocks to Buy for July 10th
08:56am, Thursday, 10'th Jul 2025
BAYRY, INSW and GOOS made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 10, 2025.
New Strong Buy Stocks for July 10th
06:35am, Thursday, 10'th Jul 2025
ASTH, LGCY, STM, BAYRY and KD have been added to the Zacks Rank #1 (Strong Buy) List on July 10, 2025.
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy
07:07am, Wednesday, 09'th Jul 2025
The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased by an experimental non-hormonal drug being developed by Bayer , according t
Bayer Begins Phase I/II Study on Cell Therapy for Eye Disease
11:36am, Tuesday, 08'th Jul 2025
BAYRY begins human trials for OpCT-001, an experimental cell therapy for treating primary photoreceptor diseases.
What Makes Bayer (BAYRY) a New Buy Stock
01:00pm, Thursday, 03'rd Jul 2025
Bayer (BAYRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Bayer Appoints Priyal Patel as Chief Financial Officer for North America
08:59am, Tuesday, 01'st Jul 2025
ST. LOUIS--(BUSINESS WIRE)--Bayer today announced the appointment of Priyal Patel as Cluster Chief Financial Officer (CFO) for North America, effective July 1, 2025. In her new role, Patel will overse
